No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache

Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading s...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boni, Laura, Odainic, Alexandru, Gancarczyk, Natalie, Kaluza, Luisa, Strassburg, Christian P., Kersting, Xenia A. K., Johnson, Joseph M., Wüllner, Ullrich, Schmidt, Susanne V., Nattermann, Jacob, Petzold, Gabor C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618412/
https://www.ncbi.nlm.nih.gov/pubmed/36310154
http://dx.doi.org/10.1186/s42466-022-00217-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618412/
https://www.ncbi.nlm.nih.gov/pubmed/36310154
http://dx.doi.org/10.1186/s42466-022-00217-5

Ejemplares similares